M/Z: 206.139


Hit 2 annotations:  Azelaic acid_[M+NH4]+; Antipyrine_[M+NH4]+


在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 1 Reference Ions Near m/z 206.139
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000007310 Reliable 206.1467 206.1465 ~ 206.1469
MzDiff: 1.3 ppm
Nα-Acetyl-L-lysine (BioDeep_00000001385)
Formula: C8H16N2O3 (188.1161)
4.91 (100%) Rattus norvegicus
[UBERON:0004359] corpus epididymis

Found 3 Sample Hits
Metabolite Species Sample
Azelaic acid

Formula: C9H16O4 (188.1049)
Adducts: [M+NH4]+ (Ppm: 1.6)
Marker Pen (NA)
3ul_0.8Mpa_RAW_20241016-PAPER PNMK
Resolution: 30μm, 315x42

Description

By writing the four English letters “PNMK” on white paper with a marker pen, and then scanning with a DESI ion source to obtain the scanning result. The signal of the chemical substances on the marker pen used appears on the channel with an m/z value of 322.1918, 323.1953, 546.4010, and etc, from the single cell deconvolution sampling layer class_4. This test data was tested by chuxiaoping from PANOMIX’s R&D laboratory.

Antipyrine

Formula: C11H12N2O (188.095)
Adducts: [M+NH4]+ (Ppm: 9.1)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Antipyrine

Formula: C11H12N2O (188.095)
Adducts: [M+NH4]+ (Ppm: 8.7)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).